BDBM321420 6-[(E)-but-2-enyl]-4-[4-chloro-5-(morpholine-4-carbonyl)-2-pyridyl]-2-methyl-1H-pyrrolo[2,3-c]pyridin-7-one::US10183009, Example 104
SMILES: C\C=C\Cn1cc(-c2cc(Cl)c(cn2)C(=O)N2CCOCC2)c2cc(C)[nH]c2c1=O
InChI Key: InChIKey=JUOWXSNIPBOTDN-ONEGZZNKSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRD9 (aa 134-239) (Homo sapiens (Human)) | BDBM321420![]() (6-[(E)-but-2-enyl]-4-[4-chloro-5-(morpholine-4-car...) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair |